The city of San Antonio, Texas, currently has 14 active clinical trials seeking participants for NASH - Nonalcoholic Steatohepatitis research studies.
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
NCT04880187
Recruiting
This study will compare the effects of AXA1125, an orally active mixture of amino acids, compared to placebo, on improving fat and inflammation (steatohepatitis) as well as fibrosis in subjects with non alcoholic steatohepatitis (NASH). as well as the safety and tolerability of AXA1125. Subjects will take one of two different doses of AXA1125 or a placebo twice daily, and a liver biopsy will be done at the beginning and end of the 48-week study.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/07/2022
Locations: American Research Corporation, San Antonio, Texas +2 locations
Conditions: Non Alcoholic Steatohepatitis (NASH)
Register for Updates
LITMUS Imaging Study
NCT05479721
Recruiting
The LITMUS Imaging Study is a prospectively recruited, observational study of patients with histologically characterised non-alcoholic fatty liver disease (NAFLD). It aims to evaluate the diagnostic performance of imaging biomarkers (ultrasound elastography and magnetic resonance biomarkers) against NAFLD histological scores in a cross-sectional analysis and the natural history of NAFLD in a longitudinal study.
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
07/26/2022
Locations: Pinnacle Clinical Research, San Antonio, Texas
Conditions: NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver, Steatosis of Liver
Register for Updates